| 产品详情 |
| Edit |   |
|---|
| Product Name | 17-AAG |
|---|
| Description | MW: 585.7. Glendanamycin (GA), a benzoquinone ansamycin antibiotic, interferes with the action of Hsp90 leading to degradation of Hsp90 client proteins. GA itself however has undesirable properties such as poor aqueous solubility and liver toxicity; therefore, numerous analogs have been synthesized, such as 17-AAG(1). 17-AAG is an HSP-90 inhibitor that displays a 100-fold higher affinity for HSP-90 derived from tumor cells compared to HSP-90 from normal cells(2). 17-AAG inhibits Akt activation and expression in tumors and synergizes with a number of antitumor agents such as taxol(3), cisplatin(4) and UCN-01 (400 nM 17-AAG, U937 cells)(5). |
|---|
| Size | 1 mg, 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; 17-Demethoxy-17-allylamino geldanamycin; 17-AAG; CP 127374; Geldanamycin,17-demethoxy-17-(2-propenylamino)-; NSC 330507; Tanespimycin |
|---|
| Gene, Accession, CAS # | CAS: 75747-14-7 |
|---|
| Catalog # | abx076601 |
|---|
| Price | |
|---|
| Order / More Info | 17-AAG from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|